RAD51 biomarker could complement next-generation sequencing in personalizing prostate cancer treatment
Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...
Kaleido Scope11h
Leavenworth and Markert published in Nature Communications
For more information, refer to the full study in Nature Communications.